Postinfantile Giant Cell Hepatitis: An Etiological and Prognostic Perspective

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Drugs and medication</td><td align="left">Methotrexate, clometacin, 6-mercaptapurine, p-aminosalicylic acid, vinyl chloride, amitriptyline, chlordiazepoxide, and chlorpromazine and herbal medicine</td></tr><tr><td align="left" colspan="2"><hr/></td></tr><tr><td align="left">Autoimmune diseases</td><td align="left">Systemic lupus erythematosus, rheumatoid arthritis, polyarthritis, ulcerative colitis, autoimmune hemolytic anemia, primary sclerosing cholangitis, and autoimmune hepatitis (AIH), polyarteritis nodosa, and primary biliary cirrhosis</td></tr><tr><td align="left" colspan="2"><hr/></td></tr><tr><td align="left">Viral causes</td><td align="left">Hepatitis A, B, C, E<br/>Epstein-Barr virus (EBV), HIV,<br/>paramyxo-like virus.<br/>herpesvirus 6A infection, and human papillomavirus.</td></tr><tr><td align="left" colspan="2"><hr/></td></tr><tr><td align="left">Miscellaneous</td><td align="left">Hypereosinophilia, chronic lymphocytic leukaemia, lymphoma, sarcoidosis, Kugelberg-Welander syndrome, hypoparathyroidism, Sickle cell anaemia, and post transplant</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Various etiological agents of post infantile giant cell hepatitis.

Hepatitis Research and Treatment

tab1

Table 1

Table 1: Postinfantile Giant Cell Hepatitis: An Etiological and Prognostic Perspective 